 MENLO PARK, Calif., Feb. 05, 2021 GLOBE NEWSWIRE -- Pacific Biosciences of California, Inc. NASDAQ: PACB Pacific Biosciences or the Company, a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock and restricted stock units RSU covering 50,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan on December 14, 2020 the 2020 Inducement Plan. 